UA6826U - Method for treating acute experimental pancreatitis - Google Patents
Method for treating acute experimental pancreatitisInfo
- Publication number
- UA6826U UA6826U UA20041209838U UA20041209838U UA6826U UA 6826 U UA6826 U UA 6826U UA 20041209838 U UA20041209838 U UA 20041209838U UA 20041209838 U UA20041209838 U UA 20041209838U UA 6826 U UA6826 U UA 6826U
- Authority
- UA
- Ukraine
- Prior art keywords
- treating acute
- acute experimental
- dose
- experimental pancreatitis
- administration
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The method for treating the acute experimental pancreatitis provides for intravenous administration of the liposomal form of Dalargin at a dose of 0.002-0.003 g in combination with intrabursal administration of Deltaran at a dose of 0.0009-0.0012 g and intra-arterial administration of free form of Dalargin into the celiac trunk at a dose of 0.001-0.002 g for 2-3 days.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UA20041209838U UA6826U (en) | 2004-12-01 | 2004-12-01 | Method for treating acute experimental pancreatitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UA20041209838U UA6826U (en) | 2004-12-01 | 2004-12-01 | Method for treating acute experimental pancreatitis |
Publications (1)
Publication Number | Publication Date |
---|---|
UA6826U true UA6826U (en) | 2005-05-16 |
Family
ID=34883914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA20041209838U UA6826U (en) | 2004-12-01 | 2004-12-01 | Method for treating acute experimental pancreatitis |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA6826U (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008091177A1 (en) | 2007-01-18 | 2008-07-31 | Otkrytoe Aktsionernoe Obschestvo 'otechestvennye Lekarstva' | Exenatide and dalargin-based medicinal preparation for treating pancreatic diabetes |
EP3556377A1 (en) | 2018-04-18 | 2019-10-23 | PVP Labs PTE. Ltd. | Antiviral immunotropic agent for the treatment of acute respiratory viral infections |
EP3622964A1 (en) | 2018-09-12 | 2020-03-18 | PVP Labs PTE. Ltd. | Agent for the treatment of skin wounds or burns |
-
2004
- 2004-12-01 UA UA20041209838U patent/UA6826U/en unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008091177A1 (en) | 2007-01-18 | 2008-07-31 | Otkrytoe Aktsionernoe Obschestvo 'otechestvennye Lekarstva' | Exenatide and dalargin-based medicinal preparation for treating pancreatic diabetes |
EP3556377A1 (en) | 2018-04-18 | 2019-10-23 | PVP Labs PTE. Ltd. | Antiviral immunotropic agent for the treatment of acute respiratory viral infections |
EP3622964A1 (en) | 2018-09-12 | 2020-03-18 | PVP Labs PTE. Ltd. | Agent for the treatment of skin wounds or burns |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL357944A1 (en) | Intradermal-penetration agents for topical local anesthetic administration | |
WO2005048942A3 (en) | Combination therapy comprising a cox-2 inhibitor and an antineoplastic agent | |
UA88464C2 (en) | Method of topical methadone administration providing systemic effect | |
EP1355563A4 (en) | METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES | |
DE69936444D1 (en) | SYSTEMIC ADMINISTRATION OF SERUM-STABLE PLASMID-LIPID PARTICLES TO CANCER THERAPY | |
WO2004006906A3 (en) | Methods for the treatment of neoplasms | |
AU2002236527A1 (en) | Nutrient supplements and methods for treating autism and for preventing the onset of autism | |
AU1718400A (en) | Method for treating pain | |
IL138979A0 (en) | Use of cannabinoids as anti-inflammatory agents | |
DE60106905D1 (en) | FORMULATIONS AND METHOD FOR THE USE OF NITROGEN MONOXIDE MIMETICS AGAINST A MALIGNANT CELL PHENOTYPE | |
ES2149264T3 (en) | THERAPEUTIC AGENT FOR THE TREATMENT OF MELANOMAS. | |
HK1107766A1 (en) | Pegylated liposomal doxorubicin in combination with ecteinescidin 743 | |
WO2005058233A3 (en) | Methods for treatment of acute pancreatitis | |
MY138883A (en) | Use of asiatic acid for treatment of cencer | |
HK1033912A1 (en) | Self-tanning compositions comprising cholesterol sulphate and dha | |
WO2004006849A3 (en) | Combinations of drugs for the treatment of neoplasms | |
UA6826U (en) | Method for treating acute experimental pancreatitis | |
UA6829U (en) | Method for treating acute experimental pancreatitis | |
UA6828U (en) | Method for treating acute experimental pancreatitis | |
UA6823U (en) | Method for treating acute experimental pancreatitis | |
EP1123100A4 (en) | Improving memory by the administration of delta 5-androstene-3 beta-ol-7,17-dione and 3 beta esters thereof | |
UA6825U (en) | Method for treating acute experimental pancreatitis | |
HK1058305A1 (en) | Combinations of dalfopristine/quinupristine with cefpirome | |
EP1173186A4 (en) | Use of tagatose to enhance key blood factors | |
TR200000728T2 (en) | The use of IFN-alpha and amantadine in the treatment of chronic hepatitis C. |